These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19818309)

  • 21. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, hepatic metabolism and disease.
    Edmison JM; Kalhan SC; McCullough AJ
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK; Winn J; Poordad F
    Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic complications of obesity.
    Diehl AM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):57-68. PubMed ID: 20202579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic complications of obesity.
    Diehl AM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):45-61. PubMed ID: 15823438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic steatosis and its relationship to transplantation.
    Imber CJ; St Peter SD; Handa A; Friend PJ
    Liver Transpl; 2002 May; 8(5):415-23. PubMed ID: 12004340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.
    Karlas T; Wiegand J; Berg T
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):195-208. PubMed ID: 23731881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease: is bariatric surgery the answer?
    Pillai AA; Rinella ME
    Clin Liver Dis; 2009 Nov; 13(4):689-710. PubMed ID: 19818313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non alcoholic fatty liver. A frequent entity with an unknown outcome].
    Barisio D'Angelo MG; Mariel Actis A; Outomuro D
    Rev Gastroenterol Peru; 2009; 29(1):44-50. PubMed ID: 19424408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.
    Koebnick C; Getahun D; Reynolds K; Coleman KJ; Porter AH; Lawrence JM; Punyanitya M; Quinn VP; Jacobsen SJ
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):597-603. PubMed ID: 19412009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
    Lo CM
    Transplantation; 2007 Feb; 83(3):265-6. PubMed ID: 17297398
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
    Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
    Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.